Seventh Sense Biosystems raises $16 mln in Series B funding

By Chris Witkowsky — 1 year ago

Seventh Sense Biosystems, which develops blood collection and diagnostic platforms, has raised $16 million in Series B funding from a group of investors. New investors in the funding were the venture capital arm of Siemens Financial Services, Novartis and Laboratory Corporation of America Holdings. Existing investors Flagship Ventures and Polaris Partners also participated in the funding round.


LabCorp Denies Takeover Rumors

By Luisa Beltran — 3 years ago

Laboratory Corporation of America Holdings said Wednesday that it has “no knowledge” pf plans by private equity firms to take over the company via an LBO. LabCorp said in a statement that it is not in current discussions with any firms. LabCorp is responding to a Mergermarket report that says a PE consortium plans to […]